[MO29] Mini-Oral Session 29　呼吸器4（EGFR-TKI 1）
【E】

[MO29-5] Updated safety and efficacy of poziotinib in Japanese patients with non-small cell lung cancer: Phase 1 study

^○Akira Ono¹, Haruko Daga², Kyounghwa Bae³, Lyndah Dreiling³, Francois Lebel³, Koichi Goto⁴ (1.Head Physician Dept of Respiratory Medicine and Thoracic Oncology Shizuoka Cancer Center, 2.Director, Department of Medical Oncology, Osaka City General Hospital, 3.Spectrum Pharmaceuticals, Inc., 4.Chief, Department of Thoracic Oncology, National Cancer Center Hospital East Principal Investigator of LC-SCRUM-Asia)